West Coast Clinical Trials Recent Visit to Korean Food and Drug Administration

Seoul, Korea / July 11, 2008 / - WCCT CEO Kenneth Kim was well received at a recent visit at the Korean Food and Drug Administration where he spoke on "Integrating Asia into Global Development" WCCT has a special expertise in recruiting and executing clinical pharmacology bridging PK trials in Asians (see press release of April 3, 2008).  For more information on WCCT's Asian bridging experience, please contact mgr@wcctrials.com.

About West Coast Clinical Trials, LLC

WCCT is an independent early phase clinical CRO with a 120-bed phase I facility with 10 telemetry equipped beds located in southern California. WCCT has a unique focus on Ethno-bridging studies along with extensive experience with healthy volunteer and specialty trials (allergy, asthma, infectious disease, pediatric, renal and vaccines). For more information, visit our Web site at http://www.wcctrials.com.

_____________________

Contact:


_____________________

Source: West Coast Clinical Trials, LLC